|
|
|

The Medical University of Vienna
More information about the Medical University of Vienna is available at http://www.meduniwien.ac.at
The Vienna group have reported the first description of amniotic fluid stem cells (AFSCs) (Hum. Reprod. 18: 1489). We have already extensive experience with AFSCs and have found that such cells can be differentiated into neurogenic cells (Am. J. Obstet. Gyn. 191:309). We have also shown that cells of the amniotic fluid can activate ectopic Oct-4 and Rex-1 promoters (Int. J. Mol. Med. 16:987) and we were involved in the publication of the proteome of amniotic fluid cells (Proteomics 4: 1145). We have technical experience with a wide variety of differentiation cell systems, including neurogenesis, myogenesis and mammary epithelial cell differentiation (Oncogene 16: 2197; Oncogene 21: 4747). Our group has extensive facilities and technical experience within cellular and molecular biology, human genetics (cytogenetics, fluorescence in situ hybridization, molecular diagnostics), human primary cell culture, flow cytometry, microscopy etc.
The following staff are involved:-
|
|
The Vienna group have reported the first description of amniotic fluid stem cells (AFSCs) (Hum. Reprod. 18: 1489) |